Phospho-Annexin I (Y21) Polyclonal Antibody

ANXA1 encodes a membrane-localized protein that binds phospholipids. Annexin A1 inhibits phospholipase A2 and has anti-inflammatory activity. Loss of function or expression of ANXA1 has been detected in multiple tumors.

The Phospho-Annexin I (Y21) Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of phosphorylated Annexin I at tyrosine 21 residue. Annexin I is a calcium-dependent phospholipid-binding protein that plays a crucial role in various cellular processes, including membrane trafficking, signal transduction, and apoptosis. The phosphorylation of Annexin I at tyrosine 21 has been implicated in the regulation of its function and cellular localization.

This polyclonal antibody has been meticulously developed using advanced immunization techniques and rigorously validated to ensure exceptional specificity and sensitivity. It exhibits minimal cross-reactivity with non-phosphorylated Annexin I and other related proteins, thereby enabling accurate and reliable detection of phosphorylated Annexin I in various biological samples.

The Phospho-Annexin I (Y21) Polyclonal Antibody demonstrates outstanding performance in a wide range of applications, including Western blotting, immunoprecipitation, immunofluorescence, and immunohistochemistry. It exhibits strong and specific staining of phosphorylated Annexin I, allowing for precise localization and visualization of this critical protein in cellular and tissue contexts.

With its superior quality and performance, the Phospho-Annexin I (Y21) Polyclonal Antibody is an indispensable tool for researchers studying the role of Annexin I phosphorylation in cellular processes and disease mechanisms. Its reliable and reproducible results make it an ideal choice for both basic research and clinical investigations.